Literature DB >> 18792402

Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF-beta3.

Shivanee Shah1, Liang Qiao.   

Abstract

Regulatory T cells (Treg) play critical roles in maintaining tolerance and preventing autoimmunity. It is not fully clear how these cells are generated and maintained. Here, we show that resting B cells are able to expand Treg. This expansion requires TGF-beta3 and signaling through the TCR and CD28. Upon activation, B cells express less TGF-beta3, which reduces their capacity to expand Treg and which also results in increased Treg death. This may ensure that B cells can function as potent professional antigen presenting cells during infections. However, in the absence of any infection, we find that B-cell-deficient microMT mice have decreased percentages of Treg in the periphery. Our data suggest that resting B cells, which may be presenting self-antigens to T cells, can expand and maintain specific Treg and thus might be involved in the prevention of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18792402     DOI: 10.1002/eji.200838201

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

1.  Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.

Authors:  Sheri Tinnell Dorsam; Emilie Vomhof-Dekrey; Rebecca J Hermann; Jodie S Haring; Travis Van der Steen; Erich Wilkerson; Goran Boskovic; James Denvir; Yulia Dementieva; Donald Primerano; Glenn Paul Dorsam
Journal:  Mol Immunol       Date:  2010-02-01       Impact factor: 4.407

2.  Enhanced renewal of regulatory T cells in relation to CD4(+) conventional T lymphocytes in the peripheral compartment.

Authors:  Jeane de Souza Nogueira; Fábio Barrozo do Canto; Caroline Fraga Cabral Gomes Nunes; Pedro Henrique Oliveira Vianna; Luciana de Souza Paiva; Alberto Nóbrega; Maria Bellio; Rita Fucs
Journal:  Immunology       Date:  2015-12-17       Impact factor: 7.397

Review 3.  Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.

Authors:  Monica K Mann; Avijit Ray; Sreemanti Basu; Christopher L Karp; Bonnie N Dittel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

4.  A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.

Authors:  Avijit Ray; Sreemanti Basu; Calvin B Williams; Nita H Salzman; Bonnie N Dittel
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

5.  Regulatory T cells in B-cell-deficient and wild-type mice differ functionally and in expression of cell surface markers.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

6.  Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.

Authors:  Bradford E Hall; Umesh D Wankhade; Joanne E Konkel; Karthik Cherukuri; Chandrasekharam N Nagineni; Kathleen C Flanders; Praveen R Arany; Wanjun Chen; Sushil G Rane; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

Review 7.  Update on the immunological pathway of negative regulation in acute insults and sepsis.

Authors:  Ying-yi Luan; Yong-ming Yao; Zhi-yong Sheng
Journal:  J Interferon Cytokine Res       Date:  2012-04-17       Impact factor: 2.607

8.  B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice.

Authors:  Lino L Teichmann; Michael Kashgarian; Casey T Weaver; Axel Roers; Werner Müller; Mark J Shlomchik
Journal:  J Immunol       Date:  2011-12-09       Impact factor: 5.422

9.  B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile.

Authors:  Jason DeFuria; Anna C Belkina; Madhumita Jagannathan-Bogdan; Jennifer Snyder-Cappione; Jordan David Carr; Yanina R Nersesova; Douglas Markham; Katherine J Strissel; Amanda A Watkins; Min Zhu; Jessica Allen; Jacqueline Bouchard; Gianluca Toraldo; Ravi Jasuja; Martin S Obin; Marie E McDonnell; Caroline Apovian; Gerald V Denis; Barbara S Nikolajczyk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 10.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.